Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trialLaetitia Collet, Maude Ardin, David Venet, et al.
Theranostics|February 12, 2020
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenograftsFlorence Coussy, Marion Lavigne, Leanne de Koning, et al.
Archives of Pathology & Laboratory Medicine|December 8, 2024
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?Amel Kime, Guillaume Bataillon, Isabelle Treilleux, et al.
Oncogene|November 4, 2022
Microsatellite instability detection in breast cancer using drop-off droplet digital PCRKhadidja Zeyneb Klouch, Marc-Henri Stern, Olfa Trabelsi-Grati, et al.
British Journal of Cancer|November 16, 2020
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration siteMaud Kamal, Sonia Lameiras, Marc Deloger, et al.
Oncogene|November 9, 2023
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trialCeline Callens, Manuel Rodrigues, Adrien Briaux, et al.
Cancers|January 21, 2022
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG NetworkClémence Romeo, Olivia Le Saux, Margaux Jacobs, et al.
NPJ Precision Oncology|April 9, 2026
Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancerAnna Salvioni, Marie Michelas, Mathilde Del, et al.
EMBO Molecular Medicine|September 7, 2022
A catalog of numerical centrosome defects in epithelial ovarian cancersJean-Philippe Morretton, Anthony Simon, Aurélie Herbette, et al.
Nature Communications|July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.
Pageof 6